Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding DMK Pharmaceuticals Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of DMK: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5351−2
Shares12.5M16.2M+3.61M (+28.8%)
Value$11.8M$17.8M+$5.98M (+50.8%)

New holders (10)

Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to DMK in Q2 2021
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC1,622,510$1.78M0.01%
Greenlight Capital Inc1,000,000$1.10M0.07%
Goldman Sachs Group Inc241,991$266.0K0.00%
Prelude Capital Management, LLC97,590$107.0K0.01%
Bank of New York Mellon Corp84,002$92.0K0.00%
Natixis38,600$42.0K0.00%
Principal Financial Group Inc32,384$36.0K0.00%
Avantax Advisory Services, Inc.32,000$35.0K0.00%
Raymond James & Associates11,608$13.0K0.00%
HighTower Advisors, LLC12,200$13.0K0.00%

Sold out (12)

Institutions that held DMK Pharmaceuticals Corp at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of DMK in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Renaissance Technologies LLC822,655$773.0K
Virtu Financial LLC346,296$326.0K
Group One Trading, L.P.88,435$83.0K
Stifel Financial Corp40,000$38.0K
Level Four Advisory Services, LLC32,000$30.0K
Qube Research & Technologies Ltd32,413$30.0K
Jane Street Group, LLC15,246$15.0K
Simplex Trading, LLC11,938$11.0K
Buckingham Capital Management, Inc.11,300$11.0K
Harbor Advisors LLC10,000$9.00K
ETF Managers Group, LLC6,216$6.00K
Federation des caisses Desjardins du Quebec500$470